The WNK1-ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib.
WNK1-ERK5 通路在卵巢癌的病理生理过程中发挥作用，并限制曲美替尼的治疗效果
期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.1217
Sánchez-Fdez Adrián, Matilla-Almazán SofÃa, Montero Juan Carlos, Del Carmen SofÃa, Abad Mar, GarcÃa-Alonso Sara, Bhattacharya Somshuvra, Calar Kristin, de la Puente Pilar, Ocaña Alberto, Pandiella Atanasio, EsparÃs-Ogando Azucena
